Simulations Plus (NASDAQ:SLP) Cut to “Hold” at Wall Street Zen

Simulations Plus (NASDAQ:SLP) was downgraded by stock analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a note issued to investors on Saturday.

Several other analysts also recently weighed in on the company. TD Cowen decreased their target price on Simulations Plus from $19.00 to $16.00 and set a “hold” rating for the company in a research note on Friday, April 10th. Weiss Ratings upgraded Simulations Plus from a “sell (d-)” rating to a “sell (d)” rating in a research note on Friday, June 5th. Two research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Simulations Plus presently has a consensus rating of “Hold” and an average price target of $21.50.

Simulations Plus Trading Down 1.0%

NASDAQ:SLP opened at $16.32 on Friday. The firm has a market capitalization of $329.66 million, a price-to-earnings ratio of -5.21 and a beta of 1.33. Simulations Plus has a 1-year low of $11.09 and a 1-year high of $21.01. The business’s fifty day moving average price is $14.79 and its 200 day moving average price is $15.57.

Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings results on Thursday, April 9th. The technology company reported $0.35 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.08. The firm had revenue of $24.29 million for the quarter, compared to analyst estimates of $21.66 million. Simulations Plus had a positive return on equity of 16.21% and a negative net margin of 77.96%. Equities analysts forecast that Simulations Plus will post 0.85 earnings per share for the current year.

Hedge Funds Weigh In On Simulations Plus

Several large investors have recently added to or reduced their stakes in the company. First Light Asset Management LLC raised its holdings in Simulations Plus by 33.7% in the 1st quarter. First Light Asset Management LLC now owns 2,632,823 shares of the technology company’s stock valued at $31,120,000 after acquiring an additional 663,906 shares in the last quarter. Ameriprise Financial Inc. raised its holdings in Simulations Plus by 25.3% in the 2nd quarter. Ameriprise Financial Inc. now owns 875,447 shares of the technology company’s stock valued at $15,277,000 after acquiring an additional 176,747 shares in the last quarter. Marshall Wace LLP raised its holdings in shares of Simulations Plus by 127.5% in the 4th quarter. Marshall Wace LLP now owns 569,783 shares of the technology company’s stock worth $10,387,000 after buying an additional 319,301 shares in the last quarter. Stephens Investment Management Group LLC raised its holdings in shares of Simulations Plus by 30.8% in the 4th quarter. Stephens Investment Management Group LLC now owns 513,728 shares of the technology company’s stock worth $9,365,000 after buying an additional 120,888 shares in the last quarter. Finally, First Eagle Investment Management LLC raised its holdings in shares of Simulations Plus by 1,898.1% in the 4th quarter. First Eagle Investment Management LLC now owns 457,155 shares of the technology company’s stock worth $8,334,000 after buying an additional 434,275 shares in the last quarter. Institutional investors and hedge funds own 78.08% of the company’s stock.

About Simulations Plus

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.